Antigen Information
General Information of This Antigen (ID: TAR0QHAVI)
| Antigen Name | Folate receptor alpha (FOLR1) |
|||||
|---|---|---|---|---|---|---|
| Gene Name | FOLR1 |
|||||
| Gene ID | ||||||
| Synonym | FOLR; Adult folate-binding protein;Folate receptor 1;Folate receptor, adult;KB cells FBP;Ovarian tumor-associated antigen MOv18 |
|||||
| Sequence |
MAQRMTTQLLLLLVWVAVVGEAQTRIAWARTELLNVCMNAKHHKEKPGPEDKLHEQCRPW
RKNACCSTNTSQEAHKDVSYLYRFNWNHCGEMAPACKRHFIQDTCLYECSPNLGPWIQQV DQSWRKERVLNVPLCKEDCEQWWEDCRTSYTCKSNWHKGWNWTSGFNKCAVGAACQPFHF YFPTPTVLCNEIWTHSYKVSNYSRGSGRCIQMWFDPAQGNPNEEVARFYAAAMSGAGPWA AWPFLLSLALMLLWLLS Click to Show/Hide
|
|||||
| Family | Ephrin family |
|||||
| Function |
Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate and folate analogs into the interior of cells. Has high affinity for folate and folic acid analogs at neutral pH. Exposure to slightly acidic pH after receptor endocytosis triggers a conformation change that strongly reduces its affinity for folates and mediates their release. Required for normal embryonic development and normal cell proliferation.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
| The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens | ||||
|---|---|---|---|---|
Ab-151
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AMT-151
|
Duostatin 5 |
Microtubule (MT) |
Pip-Val-Cit linker |
AB1380026
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AB1380026-SG3932
[1]
|
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
AB1380035
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AB1380035-SG3932
[1]
|
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
AB1380049
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AB1380049-SG3932 (DAR8)
[1]
|
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
|
|
AB1380049-SG3932 (DAR4)
[1]
|
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
AB1380083
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AB1380083-SG3932
[1]
|
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
AB1380095
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AB1380095-SG3932
[1]
|
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
AB1380117
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AB1380117-SG3932
[1]
|
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
SG3932 Linker |
Anti-FOLR1 huFR1-48
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuFR1-48-SMCC-DM1
[2]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
Anti-FOLR1 huFR1-49
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuFR1-49-SMCC-DM1
[2]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
Anti-FOLR1 huFR1-57
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuFR1-57-SMCC-DM1
[2]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
Anti-FOLR1 huFR1-65
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuFR1-65-SMCC-DM1
[2]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
Anti-FOLR1 IgG1 mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
ZW191
|
ZD06519 |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly-AM |
Anti-FOLR1 mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-FOLR1-Ala-Ala-IGN
[3]
|
Indolinobenzodiazepine dimer |
Human Deoxyribonucleic acid (hDNA) |
Ala-Ala dipeptide |
|
|
Anti-FOLR1-Val-Gln-IGN
[3]
|
Indolinobenzodiazepine dimer |
Human Deoxyribonucleic acid (hDNA) |
Val-Gln dipeptide linker |
|
|
FOLR1-ADC 13a
[4]
|
PBD dimer 13a |
Human Deoxyribonucleic acid (hDNA) |
Adipic acid-Val-Ala-PABC |
|
|
FOLR1-ADC 13b
[4]
|
PBD dimer 13b |
Human Deoxyribonucleic acid (hDNA) |
Adipic acid-Val-Ala-PABC |
|
|
FOLR1-ADC 13c
[4]
|
PBD dimer 13c |
Human Deoxyribonucleic acid (hDNA) |
Adipic acid-Val-Ala-PABC |
|
|
FOLR1-ADC 15
[4]
|
PBD dimer 13c |
Human Deoxyribonucleic acid (hDNA) |
Adipic acid-Val-CIt-PABC |
Anti-FRα antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
BAT8006
|
Exatecan |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
|
|
GenSci140
|
GSC5181 |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
Anti-FRα mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
SYS6041
[5]
|
Exatecan |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
B10 F404
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN114269749B anti-FolR1 ADC2
[6]
|
CN114269749B anti-FolR1 ADC1 Payload |
Undisclosed |
CN114269749B anti-FolR1 ADC1 Linker |
F131
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
F131-LD038
[7]
|
F131-LD038 payload |
Undisclosed |
F131-LD038 linker |
|
|
F131-LD100
[7]
|
F131-LD100 payload |
Undisclosed |
F131-LD100 linker |
|
|
F131-LD111
[7]
|
F131-LD111 payload |
Undisclosed |
F131-LD111 linker |
|
|
F131-LD101
[7]
|
F131-LD101 payload |
Undisclosed |
F131-LD101 linker |
|
|
F131-LD110
[7]
|
F131-LD110 payload |
Undisclosed |
F131-LD110 linker |
Farletuzumab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Farletuzumab ecteribulin
|
Eribulin |
Microtubule (MT) |
Mal-PEG2-Val-Cit-PABC |
|
|
Farletuzumab-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
Farletuzumab-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
Farletuzumab-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
Farletuzumab-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
Farletuzumab-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
Farletuzumab-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
Farletuzumab-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
Farletuzumab-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
|
|
FOLR1-Mal-PEG2-Val-Cit-PABC-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Mal-PEG2-Val-Cit-PABC |
|
|
FOLR1-Mal-PEG8-Val-Cit-PABC-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Mal-PEG8-Val-Cit-PABC |
|
|
FOLR1-Mal-Caproyl-Val-Cit-PABC-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Maleimide-Caproyl-Val-Cit-PABC |
|
|
FOLR1-Mal-PEG2-Ala-Ala-Asn-PABC-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Mal-PEG2-Ala-Ala-Asn-PABC |
|
|
FOLR1-Mal-PEG4-tria-PEG3-Dis-dim-PABC-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Mal-PEG4-triazole-PEG3-Disulfidyl-dimethyl-PABC |
|
|
FOLR1-Mal-PEG4-tria-PEG3-Sulfo-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Mal-PEG4-triazole-PEG3-Sulfonamide |
|
|
FOLR1-Mal-PEG2-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Mal-PEG2 |
|
|
FOLR1-Mal-PEG4-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Mal-PEG4 |
|
|
FOLR1-Suc/SPAAC-PEG4-Val-Cit-PABC-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG4-Val-Cit-PABC |
|
|
FOLR1-Suc/SPAAC-PEG3-Dis-dim-PABC-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG3-Disylfidyl-dimethyl-PABC |
|
|
FOLR1-Suc/SPAAC-PEG3-Sulfonamide-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG3-Sulfonamide |
|
|
FOLR1-Suc/SPAAC-PEG2-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG2 |
|
|
FOLR1-Suc/SPAAC-PEG4-Eribulin
[9]
|
Eribulin |
Microtubule (MT) |
Succinamide-SPAAC-PEG4 |
|
|
FOLR1-Mal-PEG-Val-Cit-PABC-Cryptophycin
[9]
|
Cryptophycin |
Microtubule (MT) |
Mal-PEG-Val-Cit-PABC |
|
|
FOLR1-Mal-Caproyl-Val-Cit-PABC-MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Maleimide-Caproyl-Val-Cit-PABC |
|
|
FOLR1-Mal-Caproyl-Val-Cit-PABC-MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimide-Caproyl-Val-Cit-PABC |
|
|
Farletuzumab-sulfo SPDB-DM4
[9]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
CN119630431A ADC-6
[10]
|
CN119630431A-ADC-1-PAYLOAD |
Undisclosed |
Undisclosed |
|
|
CN119630431A ADC-7
[10]
|
CN119630431A ADC-51 payload |
Undisclosed |
Undisclosed |
|
|
CN119630431A ADC-8
[10]
|
CN119630431A-ADC-1-PAYLOAD |
Undisclosed |
CN119630431A-ADC-5-LINKER |
Fc-silent FRalpha specific humanized IgG1 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
LY-4170156
|
Exatecan |
DNA topoisomerase 1 (TOP1) |
Mal-Polysarcosine10-Val-Ala-PABC |
FR-alpha antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN115429893A ADC16
[11]
|
CN115429893A ADC1 Payload |
Undisclosed |
CB07 linker |
FR1-21
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
FR1-21-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
FR1-21-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
FR1-21-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
FR1-21-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
FR1-21-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
FR1-21-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
FR1-21-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
FR1-21-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
FR1-48
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
FR1-48-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
FR1-48-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
FR1-48-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
FR1-48-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
FR1-48-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
FR1-48-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
FR1-48-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
FR1-48-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
FR1-49
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
FR1-49-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
FR1-49-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
FR1-49-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
FR1-49-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
FR1-49-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
FR1-49-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
FR1-49-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
FR1-49-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
FR1-57
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
FR1-57-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
FR1-57-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
FR1-57-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
FR1-57-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
FR1-57-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
FR1-57-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
FR1-57-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
FR1-57-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
FR1-65
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
FR1-65-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
FR1-65-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
FR1-65-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
FR1-65-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
FR1-65-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
FR1-65-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
FR1-65-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
FR1-65-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
H01 Y180F404
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN114269749B anti-FolR1 ADC1
[6]
|
CN114269749B anti-FolR1 ADC1 Payload |
Undisclosed |
CN114269749B anti-FolR1 ADC1 Linker |
|
|
CN114269749B anti-FolR1 ADC3
[6]
|
CN114269749B anti-FolR1 ADC3 Payload |
Undisclosed |
CN114269749B anti-FolR1 ADC1 Linker |
huFR1-21
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuFR1-21-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
HuFR1-21-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
HuFR1-21-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
HuFR1-21-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
HuFR1-21-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
HuFR1-21-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
HuFR1-21-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
HuFR1-21-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
huFR1-23
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuFR1-23-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
HuFR1-23-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
HuFR1-23-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
HuFR1-23-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
HuFR1-23-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
HuFR1-23-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
HuFR1-23-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
HuFR1-23-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
huMov19
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuMov19-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
HuMov19-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
HuMov19-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
HuMov19-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
HuMov19-sulfo-SPDB-DM4 (DAR3.8)
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
HuMov19-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
HuMov19-3-sulfo-Mal-DM4 (DAR 3.7)
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
HuMov19-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
|
|
HuMov19-3-sulfo-Mal-DM4 (DAR 8.23)
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
HuMov19-sulfo-SPDB-DM4 (DAR6.8)
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
huMOV19v1.0
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuMOV19v1.0-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
HuMOV19v1.0-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
HuMOV19v1.0-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
HuMOV19v1.0-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
HuMOV19v1.0-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
HuMOV19v1.0-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
HuMOV19v1.0-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
HuMOV19v1.0-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
huMOV19v1.6
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuMOV19v1.6-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
HuMOV19v1.6-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
HuMOV19v1.6-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
HuMOV19v1.6-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
HuMOV19v1.6-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
HuMOV19v1.6-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
HuMOV19v1.6-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
HuMOV19v1.6-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
Isumab01
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
IKS-01
[12]
|
FGX2-62 |
Human Deoxyribonucleic acid (hDNA) |
Undisclosed |
Luveltamab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Luveltamab tazevibulin
|
SC209 |
Microtubule (MT) |
DBCO-Val-Cit-PABA |
Mirvetuximab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Mirvetuximab soravtansine
[13]
|
DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
Mirvetuximab-SPP-DM1
[2]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
Mirvetuximab-SPDB-DM4
[14]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
Mirvetuximab-SMCC-DM1
[2]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
M9346A Sulfo-SPDB DM4
[2]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
M9346A-CX-DM1
[15]
|
Mertansine DM1 |
Microtubule (MT) |
triglycyl peptide linker CX |
|
|
M9346A-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
M9346A-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
M9346A-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
M9346A-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
37307297 ADC 10
[16]
|
FD-1 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 11
[16]
|
FD-1 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 21
[16]
|
FD-1 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 22
[16]
|
FD-1 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 23
[16]
|
FD-1 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 24
[16]
|
FD-2 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 25
[16]
|
FD-2 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 26
[16]
|
FD-3 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 27
[16]
|
FD-3 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 28
[16]
|
FD-9 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 29
[16]
|
FD-9 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 30
[16]
|
FD-22 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 31
[16]
|
FD-11 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 32
[16]
|
FD-23 |
Undisclosed |
Undisclosed |
|
|
37307297 ADC 33
[16]
|
FD-19 |
Undisclosed |
Undisclosed |
mirvetuximab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
IGAC-91
[17]
|
IG-L-18 Payload |
Undisclosed |
IG-L-25 linker |
Mirvetuximab (engineered cysteine HC-C118)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
M9346A-4c-Cxxx-Mal-CX-DM1
[15]
|
Mertansine DM1 |
Microtubule (MT) |
Cxxx-Mal-CX |
Mirvetuximab (engineered cysteine HC-C239)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
M9346A-4d-Cxxx-Mal-CX-DM1
[15]
|
Mertansine DM1 |
Microtubule (MT) |
Cxxx-Mal-CX |
Mirvetuximab (engineered cysteine LC-C205)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
M9346A-4a-Cxxx-Mal-CX-DM1
[15]
|
Mertansine DM1 |
Microtubule (MT) |
Cxxx-Mal-CX |
Mirvetuximab (engineered cysteine LC-C400)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
M9346A-4b-Cxxx-Mal-CX-DM1
[15]
|
Mertansine DM1 |
Microtubule (MT) |
Cxxx-Mal-CX |
Morab-003
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
39424599 ADC-10A
[18]
|
Undisclosed |
Undisclosed |
Electron-deficient sulfonamide-based cleavable linker 10 |
|
|
39424599 ADC-S32A
[18]
|
Undisclosed |
Undisclosed |
Electron-deficient Disulfide-based cleavable linker 32 |
MORAb-003
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MORAb-003 ADC1
[19]
|
Nostocyclopeptide-1 |
Undisclosed |
Maleimidyl - PEG3 - benzyl - disulfide - dimethyl linker |
|
|
MORAb-003 ADC2
[19]
|
Nostocyclopeptide-2 |
Undisclosed |
LL2 linker |
|
|
MORAb-003 ADC3
[19]
|
Nostocyclopeptide-2 |
Undisclosed |
LL3 linker |
|
|
MORAb-003 ADC4
[19]
|
Nostocyclopeptide-2 |
Undisclosed |
VCP linker |
|
|
MORAb-003 ADC5
[19]
|
Eribulin |
Microtubule (MT) |
VCP linker |
|
|
MORAb-003 ADC6
[19]
|
ER-001150828 |
Undisclosed |
Maleimidyl- (CH2)5-Val-Cit-pAB linker |
|
|
MORAb-003 ADC7
[19]
|
ER-001150828 |
Undisclosed |
Maleimidyl-PEG2-Val-Cit-pAB linker |
|
|
MORAb-003 ADC8
[19]
|
Mertansine DM1 |
Microtubule (MT) |
6-Maleimidocaproic acid |
|
|
MORAb-003 ADC9
[19]
|
Monomethyl auristatin E |
Microtubule (MT) |
Maleimidyl- (CH2)5-Val-Cit-pAB linker |
|
|
MORAb-003 ADC10
[19]
|
Auristatin F |
Microtubule (MT) |
NHS-PEG2 linker |
|
|
MORAb-003 ADC11
[19]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
MORAb-003 ADC12
[19]
|
Dolicatatin 3 |
Undisclosed |
PEG-pAB linker |
|
|
MORAb-003 ADC13
[19]
|
Dolicatatin 5 |
Microtubule (MT) |
Asn-Ala linker |
|
|
MORAb-003 ADC14
[19]
|
Dolicatatin 3 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC15
[19]
|
Dolicatatin 10 |
Undisclosed |
PEG-pAB linker |
|
|
MORAb-003 ADC16
[19]
|
Dolicatatin 14 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC17
[19]
|
Dolicatatin 14 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC18
[20]
|
Dolicatatin 14 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC19
[20]
|
Dolicatatin 14 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC20
[20]
|
Polymycin 7 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC21
[20]
|
Polymycin 7 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC22
[20]
|
Polymycin 7 |
Undisclosed |
PEG-pAB linker |
|
|
MORAb-003 ADC23
[20]
|
Polymycin 7 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC24
[20]
|
Dolicatatin 7 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC25
[20]
|
Dolicatatin 6 |
Undisclosed |
PEG-pAB linker |
|
|
MORAb-003 ADC26
[20]
|
Dolicatatin 10 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC27
[20]
|
Dolicatatin 10 |
Undisclosed |
PEG-pAB linker |
|
|
MORAb-003 ADC28
[20]
|
Dolicatatin 14 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC29
[20]
|
Dolicatatin 14 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC30
[20]
|
Dolicatatin 14 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC31
[20]
|
Dolicatatin 14 |
Undisclosed |
PEG-pAB linker |
|
|
MORAb-003 ADC32
[20]
|
Dolicatatin 14 |
Undisclosed |
Undisclosed |
|
|
MORAb-003 ADC33
[20]
|
Dolicatatin 5 |
Microtubule (MT) |
PEG-pAB linker |
Mov19
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Mov19-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
Mov19-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
Mov19-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
Mov19-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
Mov19-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
Mov19-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
Mov19-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
Mov19-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
mu-FR1-13
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MuFR1-13-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
MuFR1-13-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
MuFR1-13-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
MuFR1-13-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
MuFR1-13-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
MuFR1-13-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
MuFR1-13-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
MuFR1-13-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
mu-FR1-21
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MuFR1-21-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
MuFR1-21-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
MuFR1-21-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
MuFR1-21-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
MuFR1-21-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
MuFR1-21-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
MuFR1-21-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
MuFR1-21-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
mu-FR1-22
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MuFR1-22-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
MuFR1-22-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
MuFR1-22-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
MuFR1-22-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
MuFR1-22-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
MuFR1-22-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
MuFR1-22-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
MuFR1-22-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
mu-FR1-23
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MuFR1-23-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
MuFR1-23-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
MuFR1-23-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
MuFR1-23-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
MuFR1-23-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
MuFR1-23-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
MuFR1-23-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
MuFR1-23-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
mu-FR1-9
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MuFR1-9-PEG4-Mal-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
PEG4-Mal |
|
|
MuFR1-9-SMCC-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
MuFR1-9-SIA-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl iodoacetate (SIA) |
|
|
MuFR1-9-SPP-DM1
[8]
|
Mertansine DM1 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
MuFR1-9-sulfo-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
Sulfo-SPDB |
|
|
MuFR1-9-SPDB-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
MuFR1-9-3-sulfo-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
3-sulfo-Mal |
|
|
MuFR1-9-PEG4-Mal-DM4
[8]
|
Mertansine DM4 |
Microtubule (MT) |
PEG4-Mal |
Opugotamig
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Opugotamig olatansine
|
DM21-C |
Microtubule (MT) |
Stable cleavable peptide linker |
Rinatabart
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Rinatabart sesutecan
|
Exatecan |
DNA topoisomerase 1 (TOP1) |
T1000 |
SIBP-A12
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
SIBP-A19
|
DXd |
DNA topoisomerase 1 (TOP1) |
Mc-VASGFG |
Sofetabart
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
sofetabart mipitecan
|
Exatecan |
DNA topoisomerase 1 (TOP1) |
Mal-Polysarcosine10-Val-Ala-PABC |
Torvutatug
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Torvutatug samrotecan
|
AZ14170132 (AZ0132) |
DNA topoisomerase 1 (TOP1) |
Mal-PEG8-Val-Ala |
Undisclosed
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuIgG1-SPDB-DM4
[2]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
Anti-FolRa Iadc
[21]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
FOLR1 maytansinoid based antibody-drug conjugate
[22]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
M-DGN549
[23]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
DNA-alkylating anti-FRalpha antibody-drug conjugate
[24]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
IKS-012
[25]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
ALT-Q5
[26]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
BB-17
[27]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
39424599 ADC-S35A
[18]
|
Undisclosed |
Undisclosed |
S35 linker |
|
|
CN115429893A ADC17
[11]
|
CN115429893A ADC1 Payload |
Undisclosed |
CB07 linker |
|
|
anti-FOLR1-151-K-LOCK-D5
[28]
|
AU2023267043A1 ADC-5 Payload |
Undisclosed |
AU2023267043A1 ADC-5 Linker |
|
|
anti-FOLR1-151-C-LOCK-D5
[28]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Isumab01-C1a
[29]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Isumab01-C1b
[29]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Isumab01-C2a
[29]
|
WO2025015586A1, ADC25, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
|
|
Isumab01-C2b
[29]
|
WO2025015586A1, ADC25, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
|
|
Isumab01-C3
[29]
|
WO2025015586A1, ADC23, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
|
|
Isumab01-C4
[29]
|
compound 4 |
DNA topoisomerase I (TOP1) |
Undisclosed |
|
|
Isumab01-C5
[29]
|
compound 5 |
DNA topoisomerase I (TOP1) |
Undisclosed |
|
|
Isumab01-C6
[29]
|
WO2025015586A1, ADC24, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
|
|
Isumab01-C7
[29]
|
WO2025015586A1, ADC34, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
|
|
Isumab01-C8
[29]
|
WO2025015586A1, ADC35, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
References
